Notice2021-15796
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 26, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Monitoring Activities. Proposed study is designed to collect information about implementation, including delivery of screening and follow-up clinical services, and outcomes of the NBCCEDP.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 140 (Monday, July 26, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40055-40057]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-15796]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-21-1046; Docket No. CDC-2021-0074]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) Monitoring Activities.
Proposed study is designed to collect information about implementation,
including delivery of screening and follow-up clinical services, and
outcomes of the NBCCEDP.
DATES: CDC must receive written comments on or before September 24,
2021.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0074 by any of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://Regulations.gov">Regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#1f70727d5f7c7b7c31787069"><span class="__cf_email__" data-cfemail="fa959798ba999e99d49d958c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Breast and Cervical Cancer Early Detection Program
(NBCCEDP) Monitoring Activities--(OMB Control No. 0920-1046, Exp. 11/
30/2021)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a Revision of the information collection with the
OMB Control Number 0920-1046, titled ``National Breast and Cervical
Cancer Early Detection Program (NBCCEDP) Monitoring Activities.'' In
the previous OMB approval period, information collection consisted of
an annual NBCCEDP survey and clinic-level data collection. In the next
OMB approval period, information collection will consist of a revised
NBCCEDP survey, revised clinic-level data collection, new quarterly
program update, new service delivery projection worksheet, and the
addition of previously approved minimum data elements (MDEs; OMB
Control No. 0920-0571, Exp. 11/30/2021) to increase efficiency. The
number of respondents will remain the same and the total estimated
annualized burden will increase from 683 to 1,216.
Breast and cervical cancers are prevalent among U.S. women. In
2017, the U.S. experienced 250,520 new cases and 42,000 deaths as a
result of breast
[[Page 40056]]
cancer, as well as 12,831 new cases and 4,207 deaths as a result of
cervical cancer. Evidence shows that deaths from both breast and
cervical cancers can be avoided by increasing screening services--
mammography and PAP tests--among women. However, screening is typically
underutilized among women who are under- or uninsured, have no regular
source of healthcare, or who recently immigrated to the U.S. As a
longstanding priority within chronic disease prevention, CDC focuses on
increasing access to these cancer screenings, particularly among women
who may be at increased risk.
To improve access to cancer screening, Congress passed the Breast
and Cervical Cancer Mortality Prevention Act of 1990 (Pub. L. 106-354),
which directed CDC to create the National Breast and Cervical Cancer
Early Detection Program (NBCCEDP). The NBCCEDP currently provides
funding to 70 awardees under ``Cancer Prevention and Control Programs
for State, Territorial, and Tribal Organizations (DP17-1701).'' NBCCEDP
awardees include states or their bona fide agents; U.S. territories;
and tribes or tribal organizations. The purpose of NBCCEDP is to
increase breast and cervical cancer screening rates among women
residing within defined geographical locations (as determined by the
funded program) who are at or below 250% of the federal poverty level;
aged 40-64 years for breast cancer services, and aged 21-64 years for
cervical cancer services; and under- or uninsured.
In 2022, CDC will issue a new Notice of Funding Opportunity (DP22-
2202) to continue this mission. Consistent with programmatic changes,
the information collection plan has also been redesigned to update
existing, and add new data collection instruments, and to integrate the
previously approved MDEs into this single approval package to increase
efficiency of information collection for the NBCCEDP. This revised
information collection will allow CDC to provide routine monitoring
feedback to awardees based on their data submissions, tailor technical
assistance (TA) as needed, support program planning, and assess program
outcomes.
CDC proposes five forms of information collection. First, the
NBCCEDP survey will be submitted to CDC annually and collects
information to monitor awardees' TA needs, external funding sources,
partnerships, EBI implementation, and COVID-19 impact. Minor revisions
to survey questions and formatting reflect the program under DP22-2202.
Second, clinic-level data will be submitted to CDC at baseline and
annually for all partnering health system clinic sites--an estimated
six clinics per awardee for breast cancer data and six clinics per
awardee for cervical cancer data. Clinic-level data allow CDC to assess
health system, clinic, and patient population characteristics;
monitoring and quality improvement activities; EBI implementation; and
baseline or annual screening rates. Minor revisions were made to
variable wording, formatting (e.g., split or combined variables), and
response options to improve data quality. Third, quarterly program
updates will be submitted to CDC four times per year to monitor award
spending, service delivery, staff vacancies, program challenges and
successes, and TA needs. This is a new information collection. Fourth,
the service delivery projection worksheet will be submitted to CDC
annually to provide an estimate of the number of women served for
breast and cervical cancer. Fifth, the minimum data elements (MDEs)
will be submitted to CDC twice per year to monitor patient
demographics; breast and cervical cancer screening, diagnosis, and
treatment; timeliness of services; and patient navigation. This
information collection was previously approved (OMB No. 0920-0571, exp.
03/30/2022) and incorporated into this approval package for increased
efficiency for NBCCEDP information collection efforts.
The proposed information collections will allow CDC to gauge
progress in meeting NBCCEDP program goals and monitor implementation
activities, evaluate outcomes, and identify awardee TA needs. In
addition, findings will inform program improvement and help identify
successful activities that need to be maintained, replicated, or
expanded.
OMB approval is requested for three years. CDC requests approval
for an estimated 1,216 annual burden hours. Participation is required
for NBCCEDP awardees. There are no costs to respondents other than
their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Awardees.............. Annual NBCCEDP 70 1 45/60 53
Survey.
NBCCEDP Clinic- 70 6 45/60 315
level
Information
Collection
Instrument--Bre
ast.
NBCCEDP Clinic- 70 6 45/60 315
level
Information
Collection
Instrument--Cer
vical.
Quarterly 70 4 32/60 149
Program Update.
Service Delivery 70 1 29/60 34
Projection
Worksheet.
MDEs............ 70 2 150/60 350
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,216
----------------------------------------------------------------------------------------------------------------
[[Page 40057]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-15796 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 26, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.